Salta al contenuto principale
Ricerc@Sapienza
Toggle navigation
Home
Login
Home
Persone
elisabetta.demarinis@uniroma1.it
Elisabetta De Marinis
Assegnista di ricerca
Struttura:
DIPARTIMENTO DI SCIENZE E BIOTECNOLOGIE MEDICO-CHIRURGICHE
E-mail:
elisabetta.demarinis@uniroma1.it
Pagina istituzionale corsi di laurea
Curriculum Sapienza
Pubblicazioni
Titolo
Pubblicato in
Anno
Nuclear miR-223 affects chromatin organization and regulates Flotillin-1 gene expression in myeloid progenitors
MEDITERRANEAN JOURNAL OF HEMATOLOGY AND INFECTIOUS DISEASES
2024
Nuclear miRNAs: Gene Regulation Activities
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
2024
Plasmonic biosensors for real-time monitoring of harmful pathogens and biomolecules
2024 IEEE Research and Applications of Photonics in Defense Conference, RAPID 2024
2024
Remote adipose tissue-derived stromal cells of patients with lung adenocarcinoma generate a similar malignant microenvironment of the lung stromal counterpart
JOURNAL OF ONCOLOGY
2023
MCL1 regulates AML cells metabolism via direct interaction with HK2. Metabolic signature at onset predicts overall survival in AMLs' patients
LEUKEMIA
2023
Biomarkers in acute myeloid leukemia: From state of the art in risk classification to future challenges of RNA editing as disease predictor and therapy target
ASPECTS OF MOLECULAR MEDICINE
2023
The epigenetic/transcriptional activity of nuclear mir-223 regulates flotillin-1 expression and function in myeloid differentiation
1st Epigenetics Society International Meeting “Epigenetics of Disease and Development”
2023
Serum albumin and nucleic acids biodistribution. From molecular aspects to biotechnological applications
IUBMB LIFE
2022
The gene promoter binding activity of miR-223 induces flotillin-1 expression and function to regulate myeloid differentiation
HAEMATOLOGICA
2022
Human platelet lysate‐derived extracellular vesicles enhance angiogenesis through miR‐126
CELL PROLIFERATION
2022
Transcriptional and Metabolic Dissection of ATRA-Induced Granulocytic Differentiation in NB4 Acute Promyelocytic Leukemia Cells
CELLS
2020
Genetic lesions disrupting calreticulin 3′-untranslated region in JAK2 mutation-negative polycythemia vera
AMERICAN JOURNAL OF HEMATOLOGY
2020
Ruxolitinib binding to human serum albumin. Bioinformatics, biochemical and functional characterization in JAK2V617F+ cell models
SCIENTIFIC REPORTS
2019
HDAC inhibition by valproic acid decreases JAK2V617F levels in myeloproliferative neoplasms via up-regulation of miR-101, in vivo and in vitro
HEMASPHERE
2018
A novel germline CALR mutation affecting an evolutionary conserved region of 3’UTR in JAK2-negative siblings with Polycythemia Vera
HEMASPHERE
2018
A novel germline mutation in the 3'Untranslated region of Calreticulin gene induces JAK/STAT signaling activation and Erythrocytosis.
HAEMATOLOGICA
2018
Retinoic acid receptors. From molecular mechanisms to cancer therapy
MOLECULAR ASPECTS OF MEDICINE
2015
Epigenetic treatment of solid tumours. A review of clinical trials
CLINICAL EPIGENETICS
2015
ERC
LS1
LS1_1
LS1_4
LS4_6
LS2_8
Progetti di Ricerca
Characterization of the nuclear microRNA miR-223-mediated regulation of genes controlling normal and neoplastic hematopoiesis
© Università degli Studi di Roma "La Sapienza" - Piazzale Aldo Moro 5, 00185 Roma